0001209191-23-059885.txt : 20231228 0001209191-23-059885.hdr.sgml : 20231228 20231228160011 ACCESSION NUMBER: 0001209191-23-059885 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231226 FILED AS OF DATE: 20231228 DATE AS OF CHANGE: 20231228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCORMICK FRANK CENTRAL INDEX KEY: 0001257809 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 231522701 MAIL ADDRESS: STREET 1: C/O UCSF, 1450 3RD STREET STREET 2: RM HD-371 CITY: SAN FRANCISCO STATE: CA ZIP: 941439001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-26 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001257809 MCCORMICK FRANK C/O BRIDGEBIO 3160 PORTER DR., SUITE 250 PALO ALTO CA 94304 1 0 0 0 1 Common Stock 2023-12-26 4 S 0 100000 42.06 D 627689 I See Footnote Common Stock 472376 D This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person, as Trustee of the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 on June 15, 2023. Represents the weighted average sale price of the shares sold from $42.00 to $42.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017. /s/ Brian C. Stephenson, Attorney-in-Fact 2023-12-28